How much is an ONVO stock worth?
One share of ONVO stock can currently be purchased for approximately $3.90. How much money does Organovo make? Organovo has a market capitalization of $33.95 million and generates $2.20 million in revenue each year. The medical research company earns $-16.83 million in net income (profit) each year or ($1.36) on an earnings per share basis.
Should you buy Organovo stock?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Organovo in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Organovo stock. View analyst ratings for Organovo or view top-rated stocks.
When is Organovo's next earnings release?
View Organovo's Short Interest. When is Organovo's next earnings date? Organovo is scheduled to release its next quarterly earnings announcement on Monday, February 14th 2022. View our earnings forecast for Organovo.
What happened at Organovo’s 2021 annual meeting?
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. was convened and adjourned, without any business being conducted, due to lack of the required quorum.
See more
Is Onvo stock a buy?
Organovo Holdings Inc (NASDAQ:ONVO) The 1 analysts offering 12-month price forecasts for Organovo Holdings Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +1,114.57% increase from the last price of 2.47.
Why is Onvo stock falling?
The inability to grow revenues implies that they cannot successfully monetize their 3D bioprinting technology, and until they do, the stock price will continue to drop. With no apparent strategy and a failed merger, it's hard to see how this ship can be turned around.
Is organovo still in business?
Founded in 2007, Organovo has since collapsed to a minuscule market cap of ~$52.4M (May 2021) while still exploring potential market opportunities including externally-partnered drug discovery, internally-directed drug discovery, and clinical development of new molecular entities or repurposed in-licensed drugs.
When did organovo go public?
Organovo went public on OTC markets in 2012 via a reverse merger with shell company Real Estate Restoration and Rental, Inc. In July 2013, Organovo uplisted to the NYSE MKT.
How has Organovo's stock price performed in 2022?
Organovo's stock was trading at $3.63 on January 1st, 2022. Since then, ONVO shares have decreased by 42.4% and is now trading at $2.09. View the...
When is Organovo's next earnings date?
Organovo is scheduled to release its next quarterly earnings announcement on Tuesday, June 21st 2022. View our earnings forecast for Organovo .
How were Organovo's earnings last quarter?
Organovo Holdings, Inc. (NASDAQ:ONVO) released its quarterly earnings data on Thursday, August, 8th. The medical research company reported ($1.00)...
When did Organovo's stock split? How did Organovo's stock split work?
Shares of Organovo reverse split on the morning of Wednesday, August 19th 2020. The 1-20 reverse split was announced on Monday, August 17th 2020. T...
Who are Organovo's key executives?
Organovo's management team includes the following people: Mr. Keith E. Murphy , Exec. Chairman & Principal Exec. Officer (Age 50, Pay $397.18k)...
What is Taylor Crouch's approval rating as Organovo's CEO?
3 employees have rated Organovo CEO Taylor Crouch on Glassdoor.com . Taylor Crouch has an approval rating of 38% among Organovo's employees. This...
Who are some of Organovo's key competitors?
Some companies that are related to Organovo include Orchard Therapeutics (ORTX) , Brookline Capital Acquisition (BCAC) , SAB Biotherapeutics (SA...
What other stocks do shareholders of Organovo own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Organovo investors own include Brainstorm Cell Therapeutic...
What is Organovo's stock symbol?
Organovo trades on the NASDAQ under the ticker symbol "ONVO."